Abstract

To describe the presentation and outcomes of patients with adrenal ganglioneuromas (AGNs). Single-centre retrospective cohort study (1 January 1995 to 31 December 2019) and systematic review of literature (1 January 1980 to 19 November 2019). Diagnosed with histologically confirmed AGN. Baseline clinical, imaging and biochemical characteristics, recurrence rates and mortality. Subgroup analysis was performed on tumours with histologic elements of ganglioneuroma and pheochromocytoma (ie composite tumours). The cohort study included 45 patients with AGN, 20 (44%) of which had composite tumours. Compared to pure AGN, patients with composite tumour were older (median age, 62.5 vs. 35years, p<.001), had smaller tumours (median size, 3.9 vs. 5.7cm, p=.016) and were discovered incidentally less frequently (65% vs. 84%, p=.009). No recurrences or ganglioneuroma-specific mortality occurred during follow-up (range, 0-266months). The systematic review included 14 additional studies and 421 patients. The mean age of diagnosis was 39years, and 47% were women. AGNs were discovered incidentally in 72% of patients, were predominantly unilateral (99%) and had a mean diameter of 5.8cm and an unenhanced computed tomography (CT) attenuation of -118 to 49Hounsfield units (HU). On imaging, 69% of AGNs were homogenous, 41% demonstrated calcifications, and 40% were lobulated. AGNs are rare benign tumours that present with variable imaging features including large size, unenhanced CT attenuation >20HU, calcifications and lobulated shape. Imaging characteristics can assist in establishing a diagnosis and avoiding an unnecessary adrenalectomy. The association of pheochromocytomas with AGNs is frequent. Diagnosis should include biochemical testing.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call